Federated Hermes, Inc. Novo Cure LTD Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Federated Hermes, Inc. holds 997,444 shares of NVCR stock, worth $28.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

997,444

Previous 742,927 34.26%

Holding current value

$28.9 Million

Previous $12.7 Million 22.51%

% of portfolio

0.04%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.61 - $23.34 $3.97 Million - $5.94 Million	254,517 Added 34.26%	997,444 $15.6 Million
Q2 2024 Aug 08, 2024	BUY	$11.83 - $24.05 $483,492 - $982,923	40,870 Added 5.82%	742,927 $12.7 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $1.06 Million - $1.47 Million	85,265 Added 13.82%	702,057 $11 Million
Q4 2023 Jan 31, 2024	BUY	$11.13 - $15.78 $6.11 Million - $8.66 Million	548,852 Added 807.85%	616,792 $9.21 Million
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $1.1 Million - $2.88 Million	67,940 New	67,940 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $4,811 - $7,641	85 New	85 $6,000
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $9.37 Million - $16.2 Million	-71,825 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$124.11 - $190.17 $2.95 Million - $4.53 Million	-23,797 Reduced 24.89%	71,825 $9.49 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $3.34 Million - $5.18 Million	29,774 Added 45.22%	95,622 $16.5 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $3.82 Million - $7.33 Million	65,848 New	65,848 $7.33 Million
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $433,522 - $727,604	-7,599 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $7.41 Million - $10.2 Million	-108,542 Reduced 93.46%	7,599 $640,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $7.1 Million - $11.2 Million	114,773 Added 8389.84%	116,141 $8.69 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $2.43 Million - $3.64 Million	-57,494 Reduced 97.68%	1,368 $86,000
Q1 2019 May 10, 2019	BUY	$31.96 - $56.12 $1.88 Million - $3.3 Million	58,846 Added 367787.5%	58,862 $2.84 Million
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $5.15 Million - $9.44 Million	-179,421 Reduced 99.99%	16 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $1.87 Million - $3.06 Million	58,319 Added 48.15%	179,437 $9.4 Million
Q2 2018 Aug 10, 2018	BUY	$19.85 - $32.0 $2.4 Million - $3.87 Million	121,068 Added 242136.0%	121,118 $3.79 Million
Q1 2018 May 09, 2018	SELL	$19.3 - $23.65 $887 - $1,087	-46 Reduced 47.92%	50 $1,000
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $146 - $197	-9 Reduced 8.57%	96 $0
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $1,895 - $2,283	105	105 $2,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Novo Cure LTD Transaction History